Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Sarcopenia: A Time for Action. An SCWD Position Paper.

Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, von Haehling S, Coats AJS, Anker SD.

J Cachexia Sarcopenia Muscle. 2019 Sep 15. doi: 10.1002/jcsm.12483. [Epub ahead of print]

2.

Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.

Canepa M, Franssen FME, Olschewski H, Lainscak M, Böhm M, Tavazzi L, Rosenkranz S.

JACC Heart Fail. 2019 Oct;7(10):823-833. doi: 10.1016/j.jchf.2019.05.009. Epub 2019 Sep 11. Review.

PMID:
31521680
3.

Heart failure prevalence in the general population: SOBOTA-HF study rationale and design.

Lainscak M, Omersa D, Sedlar N, Anker SD, Farkas J.

ESC Heart Fail. 2019 Jul 25. doi: 10.1002/ehf2.12496. [Epub ahead of print]

4.

Exercise training in cardiovascular disease: are we closing the gender gap?

Kambic T, Lainscak M.

Eur J Prev Cardiol. 2019 Jul 16:2047487319864180. doi: 10.1177/2047487319864180. [Epub ahead of print] No abstract available.

PMID:
31311302
5.

Regional differences in heart failure hospitalizations, mortality, and readmissions in Slovenia 2004-2012.

Omersa D, Erzen I, Lainscak M, Farkas J.

ESC Heart Fail. 2019 Jul 2. doi: 10.1002/ehf2.12488. [Epub ahead of print]

6.

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.

Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N, Coats AJS, Metra M, Mebazaa A, Ruschitzka F, Lainscak M, Filippatos G, Seferovic PM, Meijers WC, Bayes-Genis A, Mueller T, Richards M, Januzzi JL Jr; Heart Failure Association of the European Society of Cardiology.

Eur J Heart Fail. 2019 Jun;21(6):715-731. doi: 10.1002/ejhf.1494.

PMID:
31222929
7.

Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world.

Kapelios CJ, Lainscak M, Savarese G, Laroche C, Seferovic P, Ruschitzka F, Coats A, Anker SD, Crespo-Leiro MG, Filippatos G, Piepoli MF, Rosano G, Zanolla L, Aguiar C, Murin J, Leszek P, McDonagh T, Maggioni AP, Lund LH; HF-LT Registry Investigators Group.

Eur J Heart Fail. 2019 May 27. doi: 10.1002/ejhf.1532. [Epub ahead of print]

PMID:
31132222
8.

Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.

Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF, de Boer RA, Drexel H, Ben Gal T, Hill L, Jaarsma T, Jankowska EA, Anker MS, Lainscak M, Lewis BS, McDonagh T, Metra M, Milicic D, Mullens W, Piepoli MF, Rosano G, Ruschitzka F, Volterrani M, Voors AA, Filippatos G, Coats AJS.

Eur J Heart Fail. 2019 May 26. doi: 10.1002/ejhf.1531. [Epub ahead of print]

PMID:
31129923
9.

Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry.

Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C, Piepoli MF, Crespo-Leiro MG, Lainscak M, Ponikowski P, Filippatos G, Ruschitzka F, Seferovic P, Coats AJS, Lund LH; ESC-EORP HFA Heart Failure Long-Term Registry Investigators.

Eur J Heart Fail. 2019 May 24. doi: 10.1002/ejhf.1492. [Epub ahead of print]

PMID:
31127678
10.

Cancer cachexia: an orphan with a future.

Lainscak M, Rosano GMC.

J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):3-5. doi: 10.1002/jcsm.12401. No abstract available.

11.

Distinct skeletal muscle molecular responses to pulmonary rehabilitation in chronic obstructive pulmonary disease: a cluster analysis.

Kneppers AEM, Haast RAM, Langen RCJ, Verdijk LB, Leermakers PA, Gosker HR, van Loon LJC, Lainscak M, Schols AMWJ.

J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):311-322. doi: 10.1002/jcsm.12370. Epub 2019 Jan 18.

12.

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure.

Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM.

Circulation. 2019 Mar 5;139(10):1289-1299. doi: 10.1161/CIRCULATIONAHA.118.038010.

PMID:
30586730
13.

The β-blocker uptitration in elderly with heart failure regarding biomarker levels: CIBIS-ELD substudy.

Cvetinovic N, Sekularac N, Haehling SV, Tahirovic E, Inkrot S, Lainscak M, Apostolovic S, Putnikovic B, Waagstein F, Gelbrich G, Aleksic A, Loncar G, Düngen HD.

Biomark Med. 2018 Nov;12(11):1261-1270. doi: 10.2217/bmm-2018-0136. Epub 2018 Nov 19.

PMID:
30450925
14.

Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.

Čelutkienė J, Plymen CM, Flachskampf FA, de Boer RA, Grapsa J, Manka R, Anderson L, Garbi M, Barberis V, Filardi PP, Gargiulo P, Zamorano JL, Lainscak M, Seferovic P, Ruschitzka F, Rosano GMC, Nihoyannopoulos P.

Eur J Heart Fail. 2018 Dec;20(12):1615-1633. doi: 10.1002/ejhf.1330. Epub 2018 Nov 9. Review.

PMID:
30411833
15.

Corrigendum to 'Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology' [Eur J Heart Fail 2018;20:3-15].

Corrà U, Agostoni PG, Anker SD, Coats AJS, Crespo Leiro MG, de Boer RA, Harjola VP, Hill L, Lainscak M, Lund LH, Metra M, Ponikowski P, Riley J, Seferović PM, Piepoli MF.

Eur J Heart Fail. 2018 Oct;20(10):1501. doi: 10.1002/ejhf.1186. Epub 2018 Mar 25. No abstract available.

16.

Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD).

Leermakers PA, Schols AMWJ, Kneppers AEM, Kelders MCJM, de Theije CC, Lainscak M, Gosker HR.

Sci Rep. 2018 Oct 9;8(1):15007. doi: 10.1038/s41598-018-33471-2.

17.

Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).

Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, Loncar G, Springer J, Doehner W, Lainscak M, Hasenfuß G, Anker SD, von Haehling S.

Eur J Heart Fail. 2018 Nov;20(11):1580-1587. doi: 10.1002/ejhf.1304. Epub 2018 Aug 30.

PMID:
30160804
18.

Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity.

Biolo G, Di Girolamo FG, McDonnell A, Fiotti N, Mearelli F, Situlin R, Gonelli A, Dapas B, Giordano M, Lainscak M, Grassi G, Zauli G, Secchiero P, Mekjavic I.

Front Physiol. 2018 Jul 30;9:1000. doi: 10.3389/fphys.2018.01000. eCollection 2018.

19.

Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.

Bekfani T, Pellicori P, Morris D, Ebner N, Valentova M, Sandek A, Doehner W, Cleland JG, Lainscak M, Schulze PC, Anker SD, von Haehling S.

Clin Res Cardiol. 2019 Feb;108(2):203-211. doi: 10.1007/s00392-018-1344-x. Epub 2018 Jul 26.

PMID:
30051186
20.

Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN.

Pitt B, Bakris GL, Weir MR, Freeman MW, Lainscak M, Mayo MR, Garza D, Zawadzki R, Berman L, Bushinsky DA.

ESC Heart Fail. 2018 Aug;5(4):592-602. doi: 10.1002/ehf2.12292. Epub 2018 May 16.

21.

Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.

Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, Ceconi C, Coats AJS, Drexel H, Filippatos G, Kaski JC, Lund L, Niessner A, Ponikowski P, Savarese G, Schmidt TA, Seferovic P, Wassmann S, Walther T, Lewis BS.

Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):180-188. doi: 10.1093/ehjcvp/pvy015.

PMID:
29726985
22.

Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Harjola VP, Parissis J, Brunner-La Rocca HP, Čelutkienė J, Chioncel O, Collins SP, De Backer D, Filippatos GS, Gayat E, Hill L, Lainscak M, Lassus J, Masip J, Mebazaa A, Miró Ò, Mortara A, Mueller C, Mullens W, Nieminen MS, Rudiger A, Ruschitzka F, Seferovic PM, Sionis A, Vieillard-Baron A, Weinstein JM, de Boer RA, Crespo-Leiro MG, Piepoli M, Riley JP.

Eur J Heart Fail. 2018 Jul;20(7):1081-1099. doi: 10.1002/ejhf.1204. Epub 2018 Apr 30.

23.

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.

Seferović PM, Petrie MC, Filippatos GS, Anker SD, Rosano G, Bauersachs J, Paulus WJ, Komajda M, Cosentino F, de Boer RA, Farmakis D, Doehner W, Lambrinou E, Lopatin Y, Piepoli MF, Theodorakis MJ, Wiggers H, Lekakis J, Mebazaa A, Mamas MA, Tschöpe C, Hoes AW, Seferović JP, Logue J, McDonagh T, Riley JP, Milinković I, Polovina M, van Veldhuisen DJ, Lainscak M, Maggioni AP, Ruschitzka F, McMurray JJV.

Eur J Heart Fail. 2018 May;20(5):853-872. doi: 10.1002/ejhf.1170. Epub 2018 Mar 8. Review.

24.

Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.

Düngen HD, Tscholl V, Obradovic D, Radenovic S, Matic D, Musial Bright L, Tahirovic E, Marx A, Inkrot S, Hashemi D, Veskovic J, Apostolovic S, von Haehling S, Doehner W, Cvetinovic N, Lainscak M, Pieske B, Edelmann F, Trippel T, Loncar G.

ESC Heart Fail. 2018 Apr;5(2):288-296. doi: 10.1002/ehf2.12231. Epub 2018 Feb 24.

25.

Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge.

Ameri P, Canepa M, Anker MS, Belenkov Y, Bergler-Klein J, Cohen-Solal A, Farmakis D, López-Fernández T, Lainscak M, Pudil R, Ruschitska F, Seferovic P, Filippatos G, Coats A, Suter T, Von Haehling S, Ciardiello F, de Boer RA, Lyon AR, Tocchetti CG; Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology.

Eur J Heart Fail. 2018 May;20(5):879-887. doi: 10.1002/ejhf.1165. Epub 2018 Feb 21. Review.

26.

Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease.

Pitt B, Bushinsky DA, Kitzman DW, Ruschitzka F, Metra M, Filippatos G, Rossignol P, Du Mond C, Garza D, Berman L, Lainscak M; Patiromer-204 Investigators.

ESC Heart Fail. 2018 Jun;5(3):257-266. doi: 10.1002/ehf2.12265. Epub 2018 Jan 25.

27.

Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.

Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, Crespo-Leiro MG, Guazzi M, Harjola VP, Heymans S, Hill L, Lainscak M, Lam CSP, Lund LH, Lyon AR, Mebazaa A, Mueller C, Paulus WJ, Pieske B, Piepoli MF, Ruschitzka F, Rutten FH, Seferovic PM, Solomon SD, Shah SJ, Triposkiadis F, Wachter R, Tschöpe C, de Boer RA.

Eur J Heart Fail. 2018 Jan;20(1):16-37. doi: 10.1002/ejhf.1029. Epub 2017 Oct 16. Review.

28.

Procalcitonin in heart failure: hic et nunc.

Cvetinovic N, Isakovic AM, Lainscak M, Dungen HD, Nikolic NM, Loncar G.

Biomark Med. 2017 Oct;11(10):893-903. doi: 10.2217/bmm-2017-0160. Epub 2017 Oct 4. Review.

PMID:
28976777
29.

Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).

Saitoh M, Dos Santos MR, Emami A, Ishida J, Ebner N, Valentova M, Bekfani T, Sandek A, Lainscak M, Doehner W, Anker SD, von Haehling S.

ESC Heart Fail. 2017 Nov;4(4):448-457. doi: 10.1002/ehf2.12209. Epub 2017 Sep 27.

30.

Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.

Canepa M, Straburzynska-Migaj E, Drozdz J, Fernandez-Vivancos C, Pinilla JMG, Nyolczas N, Temporelli PL, Mebazaa A, Lainscak M, Laroche C, Maggioni AP, Piepoli MF, Coats AJS, Ferrari R, Tavazzi L; ESC-HFA Heart Failure Long-Term Registry Investigators.

Eur J Heart Fail. 2018 Jan;20(1):100-110. doi: 10.1002/ejhf.964. Epub 2017 Sep 26.

31.

Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.

Corrà U, Agostoni PG, Anker SD, Coats AJS, Crespo Leiro MG, de Boer RA, Harjola VP, Hill L, Lainscak M, Lund LH, Metra M, Ponikowski P, Riley J, Seferović PM, Piepoli MF.

Eur J Heart Fail. 2018 Jan;20(1):3-15. doi: 10.1002/ejhf.979. Epub 2017 Sep 18. Review. Erratum in: Eur J Heart Fail. 2018 Oct;20(10):1501.

32.

'heartfailurematters.org', an educational website for patients and carers from the Heart Failure Association of the European Society of Cardiology: objectives, use and future directions.

Wagenaar KP, Rutten FH, Klompstra L, Bhana Y, Sieverink F, Ruschitzka F, Seferovic PM, Lainscak M, Piepoli MF, Broekhuizen BDL, Strömberg A, Jaarsma T, Hoes AW, Dickstein K.

Eur J Heart Fail. 2017 Nov;19(11):1447-1454. doi: 10.1002/ejhf.917. Epub 2017 Sep 4. Review.

33.

Heat shock protein 27 acts as a predictor of prognosis in chronic heart failure patients.

Traxler D, Lainscak M, Simader E, Ankersmit HJ, Jug B.

Clin Chim Acta. 2017 Oct;473:127-132. doi: 10.1016/j.cca.2017.08.028. Epub 2017 Aug 24.

PMID:
28844461
34.

How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders.

Lainscak M.

Card Fail Rev. 2017 Apr;3(1):33-39. doi: 10.15420/cfr.2017.2.1.

35.

Androgen status in non-diabetic elderly men with heart failure.

Loncar G, Bozic B, Neskovic AN, Cvetinovic N, Lainscak M, Prodanovic N, Dungen HD, von Haehling S, Radojicic Z, Trippel T, Putnikovic B, Markovic-Nikolic N, Popovic V.

Aging Male. 2017 Dec;20(4):215-224. doi: 10.1080/13685538.2017.1350155. Epub 2017 Jul 11.

PMID:
28696825
36.

Heart rate and its reduction in chronic heart failure and beyond.

Nikolovska Vukadinović A, Vukadinović D, Borer J, Cowie M, Komajda M, Lainscak M, Swedberg K, Böhm M.

Eur J Heart Fail. 2017 Oct;19(10):1230-1241. doi: 10.1002/ejhf.902. Epub 2017 Jun 19. Review.

37.

Increased Myogenic and Protein Turnover Signaling in Skeletal Muscle of Chronic Obstructive Pulmonary Disease Patients With Sarcopenia.

Kneppers AEM, Langen RCJ, Gosker HR, Verdijk LB, Cebron Lipovec N, Leermakers PA, Kelders MCJM, de Theije CC, Omersa D, Lainscak M, Schols AMWJ.

J Am Med Dir Assoc. 2017 Jul 1;18(7):637.e1-637.e11. doi: 10.1016/j.jamda.2017.04.016. Epub 2017 May 31.

PMID:
28578881
38.

Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, Collins SP, Doehner W, Filippatos GS, Flammer AJ, Fuhrmann V, Lainscak M, Lassus J, Legrand M, Masip J, Mueller C, Papp Z, Parissis J, Platz E, Rudiger A, Ruschitzka F, Schäfer A, Seferovic PM, Skouri H, Yilmaz MB, Mebazaa A.

Eur J Heart Fail. 2017 Jul;19(7):821-836. doi: 10.1002/ejhf.872. Epub 2017 May 30. Review.

39.

Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.

Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, Parissis J, Laroche C, Piepoli MF, Fonseca C, Mebazaa A, Lund L, Ambrosio GA, Coats AJ, Ferrari R, Ruschitzka F, Maggioni AP, Filippatos G.

Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6.

40.

Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial.

Chavanon ML, Inkrot S, Zelenak C, Tahirovic E, Stanojevic D, Apostolovic S, Sljivic A, Ristic AD, Matic D, Loncar G, Veskovic J, Zdravkovic M, Lainscak M, Pieske B, Herrmann-Lingen C, Düngen HD.

Clin Res Cardiol. 2017 Aug;106(8):645-655. doi: 10.1007/s00392-017-1101-6. Epub 2017 Mar 30.

PMID:
28361371
41.

Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy.

Omersa D, Cufer T, Marcun R, Lainscak M.

Radiol Oncol. 2016 Jun 24;51(1):15-22. doi: 10.1515/raon-2016-0037. eCollection 2017 Mar 1.

42.

Measuring self-care in patients with heart failure: A review of the psychometric properties of the European Heart Failure Self-Care Behaviour Scale (EHFScBS).

Sedlar N, Socan G, Farkas J, Mårtensson J, Strömberg A, Jaarsma T, Lainscak M.

Patient Educ Couns. 2017 Jul;100(7):1304-1313. doi: 10.1016/j.pec.2017.02.005. Epub 2017 Feb 6. Review.

43.

Factors related to self-care behaviours in heart failure: A systematic review of European Heart Failure Self-Care Behaviour Scale studies.

Sedlar N, Lainscak M, Mårtensson J, Strömberg A, Jaarsma T, Farkas J.

Eur J Cardiovasc Nurs. 2017 Apr;16(4):272-282. doi: 10.1177/1474515117691644. Epub 2017 Feb 7. Review.

44.

Under-representation of elderly and women in clinical trials.

Vitale C, Fini M, Spoletini I, Lainscak M, Seferovic P, Rosano GM.

Int J Cardiol. 2017 Apr 1;232:216-221. doi: 10.1016/j.ijcard.2017.01.018. Epub 2017 Jan 10. Review.

PMID:
28111054
45.

Echocardiographic predictors of outcome in patients with chronic obstructive pulmonary disease.

Stankovic I, Marcun R, Janicijevic A, Farkas J, Kadivec S, Ilic I, Neskovic AN, Lainscak M.

J Clin Ultrasound. 2017 May;45(4):211-221. doi: 10.1002/jcu.22433. Epub 2016 Dec 2.

PMID:
27911009
46.

Nutritional status in the elderly: misbeliefs, misconceptions and the real world.

Lainscak M, Vitale C.

Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):427-429. No abstract available.

PMID:
27900533
47.

Psychocardiology in the elderly.

Novak Sarotar B, Lainscak M.

Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):474-479. Epub 2016 Nov 28. Review.

PMID:
27896465
48.

Physical and psychological status of patients with COPD and impaired LVEF: Two bads don't make a good.

Stankovic I, Neskovic AN, Lainscak M.

Int J Cardiol. 2017 Jan 15;227:249-250. doi: 10.1016/j.ijcard.2016.11.123. Epub 2016 Nov 8. No abstract available.

PMID:
27852446
49.

National trends in heart failure hospitalization rates in Slovenia 2004-2012.

Omersa D, Farkas J, Erzen I, Lainscak M.

Eur J Heart Fail. 2016 Nov;18(11):1321-1328. doi: 10.1002/ejhf.617. Epub 2016 Sep 9.

50.

To eat or not to eat? Indicators for reduced food intake in 91,245 patients hospitalized on nutritionDays 2006-2014 in 56 countries worldwide: a descriptive analysis.

Schindler K, Themessl-Huber M, Hiesmayr M, Kosak S, Lainscak M, Laviano A, Ljungqvist O, Mouhieddine M, Schneider S, de van der Schueren M, Schütz T, Schuh C, Singer P, Bauer P, Pichard C.

Am J Clin Nutr. 2016 Nov;104(5):1393-1402. Epub 2016 Oct 12.

PMID:
27733401

Supplemental Content

Loading ...
Support Center